Happy 7-11 Day!
We hope everyone’s on their way to get their free slurpie today! For this week’s editor’s choice, we’re highlighting four articles. First, we discuss kratom, the controversial pain-relief alternative. Next, we have updates on a multiple myeloma treatment, CRISPR progress, and new insight into ankylosing spondylitis.
Sit back and enjoy the holiday and this week’s Editor’s Choice!
[/one_half] [one_half_last]
Herbal Supplement ‘Kratom’ Used as Pain-Relieving Alternative, Receives Further Research Funding
Some people swear by kratom, others are sketpical. We’re hoping this new research will shed some light on the supplement.
[/one_half_last]
[one_half]
[/one_half] [one_half_last]
Multiple Myeloma Drug ‘Xpovio’ Passes With FDA Accelerated Approval
This treatment will need to go through more trials, but has just received good news from the FDA.[/one_half_last] [one_half]
.png)
[/one_half] [one_half_last]
Plan Proposed to Use CRISPR to Edit Gene Carrying HIV by Russian Biologist
A researcher in Russia is taking strides to implement CRISPR in humans.
[/one_half_last]
[one_half]
[/one_half] [one_half_last]
New Research Suggests “Nonsense” RNA Segment Might Play Important Role in Ankylosing Spondylitis
Just because it’s called “nonsense” RNA, doesn’t mean it’s not worth understanding!
[/one_half_last]
[one_half]
